Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 52-Week High – Still a Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $9.27 and last traded at $9.0880, with a volume of 3263 shares changing hands. The stock had previously closed at $9.02.

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 1.2%

The firm has a market cap of $15.53 billion, a PE ratio of 14.27, a PEG ratio of 1.88 and a beta of 0.19. The business’s 50 day moving average price is $8.61 and its 200 day moving average price is $8.61. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.44 and a quick ratio of 5.74.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its quarterly earnings results on Monday, October 27th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 39.53% and a return on equity of 11.90%. The firm had revenue of $740.85 million for the quarter, compared to analyst estimates of $742.35 million. On average, equities research analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.